Journal of Clinical Oncology, Vol 11, 324-329, Copyright © 1993 by American Society of Clinical Oncology

ARTICLES

Surgical salvage of chemorefractory germ cell tumors

BR Murphy, ES Breeden, JP Donohue, J Messemer, W Walsh, BJ Roth and LH Einhorn
Department of Medicine, Indiana University School of Medicine, Indianapolis.

PURPOSE: Patients with disseminated germ cell tumors who relapse after salvage chemotherapy, or who progress during cisplatin-based therapy, have chemorefractory disease and a very poor prognosis. A subset of these patients will have chemorefractory but resectable disease. We have therefore evaluated the role of salvage surgery in this patient population. PATIENTS AND METHODS: We performed a retrospective review of all patients with disseminated germ cell tumors who were felt to have chemorefractory disease and underwent salvage surgery from 1977 to 1990 at Indiana University. All patients had elevated serum markers or other signs of progressive carcinoma. A total of 48 patients underwent surgery (33 retroperitoneal lymph node dissections [RPLNDs], six thoracotomies, three thoracoabdominal resections, and multiple asynchronous procedures in six patients). RESULTS: Thirty-eight of 48 patients (79%) were rendered grossly free of disease and 29 (60%) obtained a serologic remission. Ten patients (21%) remain continuously disease-free with no postoperative treatment with a median follow-up of 46 months (range, 31 to 89). Six additional patients who relapsed after salvage surgery are currently disease-free with further treatment (four with repeat surgery and two with high-dose chemotherapy and autologous bone marrow transplantation [ABMT]). CONCLUSION: Selected patients with chemorefractory but resectable germ cell tumors have definite potential for cure with salvage surgery.

This article has been cited by other articles:

				L. H. Einhorn, S. D. Williams, A. Chamness, M. J. Brames, S. M. Perkins, and R. Abonour High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors N. Engl. J. Med., July 26, 2007; 357(4): 340 - 348. [Abstract] [Full Text] [PDF]

				L. H. Einhorn, M. J. Brames, B. Juliar, and S. D. Williams Phase II Study of Paclitaxel Plus Gemcitabine Salvage Chemotherapy for Germ Cell Tumors After Progression Following High-Dose Chemotherapy With Tandem Transplant J. Clin. Oncol., February 10, 2007; 25(5): 513 - 516. [Abstract] [Full Text] [PDF]

				G. Sonpavde, T. E. Hutson, and B. J. Roth Management of Recurrent Testicular Germ Cell Tumors Oncologist, January 1, 2007; 12(1): 51 - 61. [Abstract] [Full Text] [PDF]

				J. Oldenburg, J. M. Martin, and S. D. Fossa Late Relapses of Germ Cell Malignancies: Incidence, Management, and Prognosis J. Clin. Oncol., December 10, 2006; 24(35): 5503 - 5511. [Abstract] [Full Text] [PDF]

				P. M. Bedano, M. J. Brames, S. D. Williams, B. E. Juliar, and L. H. Einhorn Phase II Study of Cisplatin Plus Epirubicin Salvage Chemotherapy in Refractory Germ Cell Tumors J. Clin. Oncol., December 1, 2006; 24(34): 5403 - 5407. [Abstract] [Full Text] [PDF]

				B. S. Carver and J. Sheinfeld Germ Cell Tumors of the Testis Ann. Surg. Oncol., November 1, 2005; 12(11): 871 - 880. [Abstract] [Full Text] [PDF]

				S. D.W. Beck, R. S. Foster, R. Bihrle, L. H. Einhorn, and J. P. Donohue Outcome Analysis for Patients With Elevated Serum Tumor Markers at Postchemotherapy Retroperitoneal Lymph Node Dissection J. Clin. Oncol., September 1, 2005; 23(25): 6149 - 6156. [Abstract] [Full Text] [PDF]

				H. J. Schmoll, R. Souchon, S. Krege, P. Albers, J. Beyer, C. Kollmannsberger, S. D. Fossa, N. E. Skakkebaek, R. de Wit, K. Fizazi, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) Ann. Onc., September 1, 2004; 15(9): 1377 - 1399. [Abstract] [Full Text] [PDF]

				H. Sakurai, H. Asamura, K. Suzuki, S.-i. Watanabe, and R. Tsuchiya Management of Primary Malignant Germ Cell Tumor of the Mediastinum Jpn. J. Clin. Oncol., July 1, 2004; 34(7): 386 - 392. [Abstract] [Full Text] [PDF]

				K. A. Kesler, J. A. Brooks, K. M. Rieger, N. S. Fineberg, L. H. Einhorn, and J. W. Brown Mediastinal metastases from testicular nonseminomatous germ cell tumors: Patterns of dissemination and predictors of long-term survival with surgery J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 913 - 923. [Abstract] [Full Text] [PDF]

				J. Vuky, M. Bains, J. Bacik, G. Higgins, D. F. Bajorin, M. Mazumdar, G. J. Bosl, and R. J. Motzer Role of Postchemotherapy Adjunctive Surgery in the Management of Patients With Nonseminoma Arising From the Mediastinum J. Clin. Oncol., February 1, 2001; 19(3): 682 - 688. [Abstract] [Full Text] [PDF]

				R. J. Motzer, J. Sheinfeld, M. Mazumdar, M. Bains, T. Mariani, J. Bacik, D. Bajorin, and G. J. Bosl Paclitaxel, Ifosfamide, and Cisplatin Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Cancer J. Clin. Oncol., June 12, 2000; 18(12): 2413 - 2418. [Abstract] [Full Text] [PDF]

				P. Porcu, S. Bhatia, M. Sharma, and L. H. Einhorn Results of Treatment After Relapse From High-Dose Chemotherapy in Germ Cell Tumors J. Clin. Oncol., March 13, 2000; 18(6): 1181 - 1186. [Abstract] [Full Text] [PDF]

				K. A. Kesler, K. M. Rieger, K. N. Ganjoo, M. Sharma, N. S. Fineberg, L. H. Einhorn, and J. W. Brown PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM CELL TUMORS: THE INFLUENCE OF POSTCHEMOTHERAPY PATHOLOGY ON LONG-TERM SURVIVAL AFTER SURGERY J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 692 - 701. [Abstract] [Full Text] [PDF]

				M. Rivoire, E. Voiglio, P. Kaemmerlen, I. Treilleux, P. Biron, and J. P. Droz SALVAGE RESECTION OF A CHEMOREFRACTORY MEDIASTINAL GERM CELL TUMOR J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1124 - 1126. [Full Text]